INO-5401

INO-5401 · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INO-5401, covering 2025-07-10 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) [Phase 1, Phase 2]

See pricing